Tokyo Tape
Sign in
← Torii Pharmaceutical

Annual report

4551.TEDINET S100VH2F
Period2024-01-01 → 2024-12-31
Filed2025-03-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
MetricValuePeriodScopeSource row
Revenue¥60.4bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥54.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥48.9bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥47.0bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥41.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income¥6.8bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income¥5.0bn2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥6.9bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥5.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥5.5bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥4.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥6.7bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax¥5.6bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥5.0bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥4.1bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥3.9bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.4bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.5bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥140.7bnat 2024-12-31StandaloneAssets
Total assets¥133.4bnat 2023-12-31StandaloneAssets
Total assets¥133.7bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥130.8bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥126.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥19.1bnat 2024-12-31StandaloneLiabilities
Total liabilities¥13.3bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥121.5bnat 2024-12-31StandaloneNet assets
Net assets / equity¥120.1bnat 2023-12-31StandaloneNet assets
Net assets / equity¥119.2bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥117.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥115.1bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.3bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥5.0bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥30.8bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥34.7bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥45.4bnat 2022-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥58.4bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥61.6bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥3.6bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥2.4bn2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥156m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥3.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.6bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥3.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥13.7bn2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥7.6bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥3.9bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥3.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.7bn2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥179.382024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥146.62023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥140.392022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥120.132021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥124.472020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥124.462020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1202024-01-01 → 2024-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1202023-01-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,323.33at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,274.45at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,243.08at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,165.38at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,097.55at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio86.4%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.0%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.2%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio89.5%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE4.2%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE3.4%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE3.3%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE2.9%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE3.1%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued28,800,000at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees592at 2024-12-31StandaloneNumber of employees
Employees583at 2023-12-31StandaloneNumber of employees
Employees563at 2022-12-31dStandaloneNumber of employees
Employees560at 2021-12-31dStandaloneNumber of employees
Employees568at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2024-12-31592 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 974
ItemContextValueUnit
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember19908000000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember5035000000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember6798000000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember0JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember4000000JPY
Interest on securities noiPrior1YearDuration_NonConsolidatedMember287000000JPY
Interest on securities noiCurrentYearDuration_NonConsolidatedMember353000000JPY
Dividends income noiPrior1YearDuration_NonConsolidatedMember112000000JPY
Dividends income noiCurrentYearDuration_NonConsolidatedMember106000000JPY
Other noiPrior1YearDuration_NonConsolidatedMember20000000JPY
Other noiCurrentYearDuration_NonConsolidatedMember22000000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember421000000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember486000000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember0JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember0JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember101000000JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember81000000JPY
Loss on investments in partnership noePrior1YearDuration_NonConsolidatedMember46000000JPY
Loss on investments in partnership noeCurrentYearDuration_NonConsolidatedMember267000000JPY
Cancellation penalty noePrior1YearDuration_NonConsolidatedMember0JPY
Cancellation penalty noeCurrentYearDuration_NonConsolidatedMember－JPY
Other noePrior1YearDuration_NonConsolidatedMember0JPY
Other noeCurrentYearDuration_NonConsolidatedMember10000000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember149000000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember358000000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember5307000000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember6926000000JPY
Gain on sales of investment securities eiPrior1YearDuration_NonConsolidatedMember349000000JPY
Gain on sales of investment securities eiCurrentYearDuration_NonConsolidatedMember－JPY
Extraordinary incomePrior1YearDuration_NonConsolidatedMember349000000JPY
Extraordinary incomeCurrentYearDuration_NonConsolidatedMember－JPY
Loss on retirement of noncurrent assets elPrior1YearDuration_NonConsolidatedMember36000000JPY
Loss on retirement of noncurrent assets elCurrentYearDuration_NonConsolidatedMember200000000JPY
Loss on sales of investment securities elPrior1YearDuration_NonConsolidatedMember26000000JPY
Loss on sales of investment securities elCurrentYearDuration_NonConsolidatedMember－JPY
Extraordinary lossPrior1YearDuration_NonConsolidatedMember63000000JPY
Extraordinary lossCurrentYearDuration_NonConsolidatedMember200000000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember5593000000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember6725000000JPY
Income taxes currentPrior1YearDuration_NonConsolidatedMember1824000000JPY
Income taxes currentCurrentYearDuration_NonConsolidatedMember1619000000JPY
Income taxes deferredPrior1YearDuration_NonConsolidatedMember-350000000JPY
Income taxes deferredCurrentYearDuration_NonConsolidatedMember63000000JPY
Income taxesPrior1YearDuration_NonConsolidatedMember1473000000JPY
Income taxesCurrentYearDuration_NonConsolidatedMember1682000000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember4119000000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember5042000000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalStockMember5190000000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember6416000000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember37000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass